M&A Hope for Onyx? (ONXX)

Photo of Jon C. Ogg
By Jon C. Ogg Published

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) is surging on reports by Bloomberg that the company is exploring strategic alternatives, which would imply a potential merger or acquisition of or by the company.  Shares are now up 13.5% at $42.85 on over 5-times normal trading volume of 5.8 million shares with more than one-hour until the close.  Shares hit a new 52-week high of $46.07 today.

Contact [email protected] for any questions or corrections.

Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. www.247wallst.com.

Continue Reading

Top Gaining Stocks

WDC Vol: 2,925,203
AMD
AMD Vol: 11,658,093
ANET Vol: 2,287,796
DELL Vol: 2,881,261
ON Vol: 2,726,273

Top Losing Stocks

CTRA Vol: 73,319,495
ORLY Vol: 3,964,332
AZO Vol: 89,319
STZ Vol: 802,216
TSCO Vol: 1,896,374